EVI is seeking a visionary Executive Director (ED) with a track record in health product development and mobilizing resources for innovative programmes.

New call launched on 15 October.

Second call for training modules now open

We are pleased to share with you the EVI Annual Report 2017. You can download or view it using the following link. We hope you have an interesting read.

New article published on 17 July 2018 in npj  Vaccines: “Down-selection of the VAR2CSA DBL1-2 expressed in E. coli as a lead antigen for placental malaria vaccine development”.

On 20/21 November, EVI will celebrate its 20th anniversary with a symposium in Heidelberg, Germany. A draft agenda is now available.

If you are interested in attending in the symposium please fill in the application form using the following LINK. We will contact you in due course.

See attached document for more information surrounding the symposium.

First call for training modules

EVI and Processing personal data on the basis of the EU/EEA General Data Protection Regulation